Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model.

[1]  Zhipeng Chen,et al.  Research Progress on Cell Membrane-Coated Biomimetic Delivery Systems , 2021, Frontiers in Bioengineering and Biotechnology.

[2]  Dan Li,et al.  Biodegradable Hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB/ROS signaling. , 2021, International immunopharmacology.

[3]  B. Baradaran,et al.  Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy. , 2021, Small.

[4]  J. Wan,et al.  Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines , 2020, Nature Communications.

[5]  Z. Pang,et al.  Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles , 2019, Cells.

[6]  C. Patra,et al.  Nanomedicine for Cancer Therapy Using Autophagy: An Overview. , 2019, Current topics in medicinal chemistry.

[7]  Gang Liu,et al.  Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment , 2018, Science and technology of advanced materials.

[8]  Ronnie H. Fang,et al.  Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis , 2018, Nature Nanotechnology.

[9]  Sara Soares,et al.  Nanomedicine: Principles, Properties, and Regulatory Issues , 2018, Front. Chem..

[10]  Haiyan Chen,et al.  The potential of biomimetic nanoparticles for tumor-targeted drug delivery. , 2018, Nanomedicine.

[11]  Yibing Huang,et al.  Co‐administration of kla‐TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice , 2018, Chemical biology & drug design.

[12]  Ding Ding,et al.  Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.

[13]  Ronnie H. Fang,et al.  Cell Membrane Coating Nanotechnology , 2018, Advanced materials.

[14]  C. Scott,et al.  Clearance of intracellular Klebsiella pneumoniae infection using gentamicin‐loaded nanoparticles , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Juan Li,et al.  Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications. , 2018, Bioconjugate chemistry.

[16]  Khaled Greish,et al.  Nanomedicine: is it lost in translation? , 2018, Therapeutic delivery.

[17]  Edmond J. Breen,et al.  Red blood cells are dynamic reservoirs of cytokines , 2018, Scientific Reports.

[18]  K. Cai,et al.  Design of nanocarriers based on complex biological barriers in vivo for tumor therapy , 2017 .

[19]  O. Sibila,et al.  INVITED REVIEW SERIES: RESPIRATORY INFECTIONS IN THE ASIA-PACIFIC REGION , 2017 .

[20]  E. Miao,et al.  Programmed cell death as a defence against infection , 2017, Nature Reviews Immunology.

[21]  Dan Peer,et al.  Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. , 2017, ACS nano.

[22]  G. Qiao,et al.  Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers , 2016, Nature Microbiology.

[23]  J. F. Burrows,et al.  Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages , 2015, Particle and Fibre Toxicology.

[24]  D. Moranta,et al.  Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes , 2015, Cellular microbiology.

[25]  B. Mihailova,et al.  Blood compatibility of magnesium and its alloys. , 2015, Acta biomaterialia.

[26]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[27]  J. Quigley,et al.  Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[28]  R. Titball,et al.  Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei. , 2013, International journal of antimicrobial agents.

[29]  H. Ceri,et al.  ntibiotic resistance of mixed biofilms in cystic fibrosis : impact of emerging icroorganisms on treatment of infection usana , 2012 .

[30]  N. Nakasone,et al.  Inflammasome activation via intracellular NLRs triggered by bacterial infection , 2012, Cellular microbiology.

[31]  A. Aderem,et al.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria , 2010, Nature Immunology.

[32]  A. Walubo,et al.  The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration. , 2005, International journal of antimicrobial agents.

[33]  D. Raoult,et al.  Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria , 2001, Antimicrobial Agents and Chemotherapy.